Seattle, WA (June 21, 2012) – Fenwick & West congratulates Stephen Graham, Robert Hulse and Michael Shuster for being selected as “Life Sciences Stars” in the inaugural edition of Euromoney’s LMG Life Sciences 2012.
Distinguished as leading practitioners in the country, the trio was identified for their outstanding contributions to the life sciences industry. Stephen Graham, Co-Chair of the firm’s Life Science’s Group, was honored for his transactional work, while Michael Shuster, Co-Chair of the firm’s Life Sciences Group and IP partner Robert Hulse were recognized for their patent work in the life sciences industry.
The research involved over 1,000 surveys and interviews with nearly 600 attorneys in the United States, as well as a review of public information and feedback from clients within the industry. Compiled through a qualitative process of peer opinion, market feedback and independent research, the list highlights preeminent attorneys working in the life sciences sector.
About LMG Life Sciences 2012
LMG Life Sciences 2012 is a new guide from LMG Life Sciences, published by the Legal Media Group in association with Euromoney Institutional Investor. The publication takes a multi-disciplinary approach to the legal industry servicing companies in the biotech, agritech, pharmaceutical and medical device industries. LMG Life Sciences 2012 strives to be the ultimate resource for in-house counsel identifying leading lawyers and firms in the intellectual property, regulatory, transactional and non-IP litigation practice groups, all of which play important roles in guiding a product through its lifecycle.
About the Fenwick & West Life Sciences Group
Fenwick & West's Life Sciences Group consists of more than 60 attorneys and scientists who provide a broad mix of corporate, intellectual property and litigation services to private companies, public companies, investors and research institutions. Many of our Life Sciences Group attorneys have had scientific and research experience prior to their legal careers, and a number have doctorate degrees in disciplines such as molecular biology, organic chemistry, electrical engineering, and immunology. The firm was ranked as a "Top Technology & Life Sciences Law Firm" by InterContinental Finance Magazine in its 2011 Highly Commended - Top Tier Firm listing. Two of its partners were recognized by the Daily Journal in 2011 as among the top 25 biotechnology lawyers in California.